Chris Picardo focuses on startups that combine wet-lab biology with machine learning, and before becoming an investor he worked in finance and strategy at the startup Rockets of Awesome and later backed both life-science and consumer companies at Invus. Today he sits on the boards of early biotech companies like Archon Biosciences and Terray Therapeutics, and outside of work he wrote a statistics thesis using Major League Baseball pitching data, swam for four years on his college team, and plays jazz saxophone.